尿検査の世界市場：製品別、用途別、エンドユーザー別、地域別、機会、予測、2017年～2031年

世界の尿検査の市場は、予測期間の2024年～2031年に5.77%のCAGRで拡大し、2023年の41億1,000万米ドルから2031年には64億4,000万米ドルに成長すると予測されています。

世界の尿検査市場の大幅な拡大は、在宅検査への需要の高まり、大手企業間の共同努力、有利な技術進歩、予防ヘルスケアの重視、慢性疾患の増加（特に高齢化層）など、さまざまな推進力に起因しています。

セルフケアとオーダーメイドの健康管理を好む一般大衆に後押しされ、家庭用尿検査機器への傾倒が高まっています。これらの使いやすいツールは、独立した健康モニタリングを可能にし、潜在的な健康問題の早期発見と対処を容易にします。業界の主要企業間のパートナーシップは、専門知識、資源、技術力を結集して共同イノベーションを刺激します。このようなパートナーシップは、洗練された尿検査ソリューションの進歩を促進し、世界の尿検査市場のプレゼンスを拡大し、製品提供を充実させます。人工知能（AI）、自動化、携帯機器を中心とした絶え間ない進歩は、尿検査の状況を一変させる。これらの進歩は、診断プロセスのスピード、精度、利便性を著しく向上させ、それによってヘルスケアプロバイダーと個人の両方に力を与えます。

ヘルスケアの動向はますます予防対策に重点を置くようになっており、病気の早期発見のための尿検査ツールの採用と開発を奨励しています。積極的な健康モニタリングは、病気が深刻化する前に予防するという目的に合致しています。慢性疾患の急増と世界の高齢化が相まって、頻尿検査の必要性が高まっています。加齢に伴う健康への懸念が高まる中、効率的で正確な診断機器への需要が高まり、世界の尿検査市場の拡大を後押ししています。このように相互に関連する要素が、尿検査の世界市場をダイナミックに成長させ、世界中の個人や地域社会の進化するヘルスケアニーズに対応できるように形成しています。

当レポートでは、世界の尿検査市場について調査し、市場の概要とともに、製品別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 世界の尿検査市場の見通し、2017年～2031年

• 市場規模と予測
• 製品別
• 用途別
• エンドユーザー別
• 地域別
• 企業別市場シェア（%）、2023年

第5章 世界の尿検査市場の見通し、地域別、2017年～2031年

• 北米
• 欧州
• 南米
• アジア太平洋
• 中東・アフリカ

第6章 市場マッピング、2023年

第7章 マクロ環境と産業構造

• 需給分析
• 輸出入分析
• バリューチェーン分析
• PESTEL分析
• ポーターのファイブフォース分析

第8章 市場力学

第9章 規制の枠組みとイノベーション

第10章 主要参入企業の情勢

第11章 価格分析

第12章 ケーススタディ

第13章 主要企業の見通し

• F. Hoffmann-La Roche Ltd.
• Danaher Corporation
• Cardinal Health, Inc.
• Sysmex Corporation
• Quidel Corporation
• Siemens Healthineers AG
• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• Bio-Rad Laboratories, Inc.
• EKF Diagnostics
• Becton, Dickinson and Company

第14章 戦略的提言

第15章 お問合せと免責事項

List of Tables

• Table 1. Pricing Analysis of Products from Key Players
• Table 2. Competition Matrix of Top 5 Market Leaders
• Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. Global Urinalysis Market, By Value, in USD Billion, 2017-2031F
• Figure 2. Global Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
• Figure 3. Global Urinalysis Market Share (%), By Product, 2017-2031F
• Figure 4. Global Urinalysis Market Share (%), By Application, 2017-2031F
• Figure 5. Global Urinalysis Market Share (%), By End-user, 2017-2031F
• Figure 6. Global Urinalysis Market Share (%), By Region, 2017-2031F
• Figure 7. North America Urinalysis Market, By Value, in USD Billion, 2017-2031F
• Figure 8. North America Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
• Figure 9. North America Urinalysis Market Share (%), By Product, 2017-2031F
• Figure 10. North America Urinalysis Market Share (%), By Application, 2017-2031F
• Figure 11. North America Urinalysis Market Share (%), By End-user, 2017-2031F
• Figure 12. North America Urinalysis Market Share (%), By Country, 2017-2031F
• Figure 13. United States Urinalysis Market, By Value, in USD Billion, 2017-2031F
• Figure 14. United States Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
• Figure 15. United States Urinalysis Market Share (%), By Product, 2017-2031F
• Figure 16. United States Urinalysis Market Share (%), By Application, 2017-2031F
• Figure 17. United States Urinalysis Market Share (%), By End-user, 2017-2031F
• Figure 18. Canada Urinalysis Market, By Value, in USD Billion, 2017-2031F
• Figure 19. Canada Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
• Figure 20. Canada Urinalysis Market Share (%), By Product, 2017-2031F
• Figure 21. Canada Urinalysis Market Share (%), By Application, 2017-2031F
• Figure 22. Canada Urinalysis Market Share (%), By End-user, 2017-2031F
• Figure 23. Mexico Urinalysis Market, By Value, in USD Billion, 2017-2031F
• Figure 24. Mexico Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
• Figure 25. Mexico Urinalysis Market Share (%), By Product, 2017-2031F
• Figure 26. Mexico Urinalysis Market Share (%), By Application, 2017-2031F
• Figure 27. Mexico Urinalysis Market Share (%), By End-user, 2017-2031F
• Figure 28. Europe Urinalysis Market, By Value, in USD Billion, 2017-2031F
• Figure 29. Europe Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
• Figure 30. Europe Urinalysis Market Share (%), By Product, 2017-2031F
• Figure 31. Europe Urinalysis Market Share (%), By Application, 2017-2031F
• Figure 32. Europe Urinalysis Market Share (%), By End-user, 2017-2031F
• Figure 33. Europe Urinalysis Market Share (%), By Country, 2017-2031F
• Figure 34. Germany Urinalysis Market, By Value, in USD Billion, 2017-2031F
• Figure 35. Germany Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
• Figure 36. Germany Urinalysis Market Share (%), By Product, 2017-2031F
• Figure 37. Germany Urinalysis Market Share (%), By Application, 2017-2031F
• Figure 38. Germany Urinalysis Market Share (%), By End-user, 2017-2031F
• Figure 39. France Urinalysis Market, By Value, in USD Billion, 2017-2031F
• Figure 40. France Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
• Figure 41. France Urinalysis Market Share (%), By Product, 2017-2031F
• Figure 42. France Urinalysis Market Share (%), By Application, 2017-2031F
• Figure 43. France Urinalysis Market Share (%), By End-user, 2017-2031F
• Figure 44. Italy Urinalysis Market, By Value, in USD Billion, 2017-2031F
• Figure 45. Italy Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
• Figure 46. Italy Urinalysis Market Share (%), By Product, 2017-2031F
• Figure 47. Italy Urinalysis Market Share (%), By Application, 2017-2031F
• Figure 48. Italy Urinalysis Market Share (%), By End-user, 2017-2031F
• Figure 49. United Kingdom Urinalysis Market, By Value, in USD Billion, 2017-2031F
• Figure 50. United Kingdom Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
• Figure 51. United Kingdom Urinalysis Market Share (%), By Product, 2017-2031F
• Figure 52. United Kingdom Urinalysis Market Share (%), By Application, 2017-2031F
• Figure 53. United Kingdom Urinalysis Market Share (%), By End-user, 2017-2031F
• Figure 54. Russia Urinalysis Market, By Value, in USD Billion, 2017-2031F
• Figure 55. Russia Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
• Figure 56. Russia Urinalysis Market Share (%), By Product, 2017-2031F
• Figure 57. Russia Urinalysis Market Share (%), By Application, 2017-2031F
• Figure 58. Russia Urinalysis Market Share (%), By End-user, 2017-2031F
• Figure 59. Netherlands Urinalysis Market, By Value, in USD Billion, 2017-2031F
• Figure 60. Netherlands Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
• Figure 61. Netherlands Urinalysis Market Share (%), By Product, 2017-2031F
• Figure 62. Netherlands Urinalysis Market Share (%), By Application, 2017-2031F
• Figure 63. Netherlands Urinalysis Market Share (%), By End-user, 2017-2031F
• Figure 64. Spain Urinalysis Market, By Value, in USD Billion, 2017-2031F
• Figure 65. Spain Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
• Figure 66. Spain Urinalysis Market Share (%), By Product, 2017-2031F
• Figure 67. Spain Urinalysis Market Share (%), By Application, 2017-2031F
• Figure 68. Spain Urinalysis Market Share (%), By End-user, 2017-2031F
• Figure 69. Turkey Urinalysis Market, By Value, in USD Billion, 2017-2031F
• Figure 70. Turkey Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
• Figure 71. Turkey Urinalysis Market Share (%), By Product, 2017-2031F
• Figure 72. Turkey Urinalysis Market Share (%), By Application, 2017-2031F
• Figure 73. Turkey Urinalysis Market Share (%), By End-user, 2017-2031F
• Figure 74. Poland Urinalysis Market, By Value, in USD Billion, 2017-2031F
• Figure 75. Poland Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
• Figure 76. Poland Urinalysis Market Share (%), By Product, 2017-2031F
• Figure 77. Poland Urinalysis Market Share (%), By Application, 2017-2031F
• Figure 78. Poland Urinalysis Market Share (%), By End-user, 2017-2031F
• Figure 79. South America Urinalysis Market, By Value, in USD Billion, 2017-2031F
• Figure 80. South America Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
• Figure 81. South America Urinalysis Market Share (%), By Product, 2017-2031F
• Figure 82. South America Urinalysis Market Share (%), By Application, 2017-2031F
• Figure 83. South America Urinalysis Market Share (%), By End-user, 2017-2031F
• Figure 84. South America Urinalysis Market Share (%), By Country, 2017-2031F
• Figure 85. Brazil Urinalysis Market, By Value, in USD Billion, 2017-2031F
• Figure 86. Brazil Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
• Figure 87. Brazil Urinalysis Market Share (%), By Product, 2017-2031F
• Figure 88. Brazil Urinalysis Market Share (%), By Application, 2017-2031F
• Figure 89. Brazil Urinalysis Market Share (%), By End-user, 2017-2031F
• Figure 90. Argentina Urinalysis Market, By Value, in USD Billion, 2017-2031F
• Figure 91. Argentina Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
• Figure 92. Argentina Urinalysis Market Share (%), By Product, 2017-2031F
• Figure 93. Argentina Urinalysis Market Share (%), By Application, 2017-2031F
• Figure 94. Argentina Urinalysis Market Share (%), By End-user, 2017-2031F
• Figure 95. Asia-Pacific Urinalysis Market, By Value, in USD Billion, 2017-2031F
• Figure 96. Asia-Pacific Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
• Figure 97. Asia-Pacific Urinalysis Market Share (%), By Product, 2017-2031F
• Figure 98. Asia-Pacific Urinalysis Market Share (%), By Application, 2017-2031F
• Figure 99. Asia-Pacific Urinalysis Market Share (%), By End-user, 2017-2031F
• Figure 100. Asia-Pacific Urinalysis Market Share (%), By Country, 2017-2031F
• Figure 101. India Urinalysis Market, By Value, in USD Billion, 2017-2031F
• Figure 102. India Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
• Figure 103. India Urinalysis Market Share (%), By Product, 2017-2031F
• Figure 104. India Urinalysis Market Share (%), By Application, 2017-2031F
• Figure 105. India Urinalysis Market Share (%), By End-user, 2017-2031F
• Figure 106. China Urinalysis Market, By Value, in USD Billion, 2017-2031F
• Figure 107. China Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
• Figure 108. China Urinalysis Market Share (%), By Product, 2017-2031F
• Figure 109. China Urinalysis Market Share (%), By Application, 2017-2031F
• Figure 110. China Urinalysis Market Share (%), By End-user, 2017-2031F
• Figure 111. Japan Urinalysis Market, By Value, in USD Billion, 2017-2031F
• Figure 112. Japan Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
• Figure 113. Japan Urinalysis Market Share (%), By Product, 2017-2031F
• Figure 114. Japan Urinalysis Market Share (%), By Application, 2017-2031F
• Figure 115. Japan Urinalysis Market Share (%), By End-user, 2017-2031F
• Figure 116. Australia Urinalysis Market, By Value, in USD Billion, 2017-2031F
• Figure 117. Australia Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
• Figure 118. Australia Urinalysis Market Share (%), By Product, 2017-2031F
• Figure 119. Australia Urinalysis Market Share (%), By Application, 2017-2031F
• Figure 120. Australia Urinalysis Market Share (%), By End-user, 2017-2031F
• Figure 121. Vietnam Urinalysis Market, By Value, in USD Billion, 2017-2031F
• Figure 122. Vietnam Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
• Figure 123. Vietnam Urinalysis Market Share (%), By Product, 2017-2031F
• Figure 124. Vietnam Urinalysis Market Share (%), By Application, 2017-2031F
• Figure 125. Vietnam Urinalysis Market Share (%), By End-user, 2017-2031F
• Figure 126. South Korea Urinalysis Market, By Value, in USD Billion, 2017-2031F
• Figure 127. South Korea Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
• Figure 128. South Korea Urinalysis Market Share (%), By Product, 2017-2031F
• Figure 129. South Korea Urinalysis Market Share (%), By Application, 2017-2031F
• Figure 130. South Korea Urinalysis Market Share (%), By End-user, 2017-2031F
• Figure 131. Indonesia Urinalysis Market, By Value, in USD Billion, 2017-2031F
• Figure 132. Indonesia Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
• Figure 133. Indonesia Urinalysis Market Share (%), By Product, 2017-2031F
• Figure 134. Indonesia Urinalysis Market Share (%), By Application, 2017-2031F
• Figure 135. Indonesia Urinalysis Market Share (%), By End-user, 2017-2031F
• Figure 136. Philippines Urinalysis Market, By Value, in USD Billion, 2017-2031F
• Figure 137. Philippines Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
• Figure 138. Philippines Urinalysis Market Share (%), By Product, 2017-2031F
• Figure 139. Philippines Urinalysis Market Share (%), By Application, 2017-2031F
• Figure 140. Philippines Urinalysis Market Share (%), By End-user, 2017-2031F
• Figure 141. Middle East & Africa Urinalysis Market, By Value, in USD Billion, 2017-2031F
• Figure 142. Middle East & Africa Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
• Figure 143. Middle East & Africa Urinalysis Market Share (%), By Product, 2017-2031F
• Figure 144. Middle East & Africa Urinalysis Market Share (%), By Application, 2017-2031F
• Figure 145. Middle East & Africa Urinalysis Market Share (%), By End-user, 2017-2031F
• Figure 146. Middle East & Africa Urinalysis Market Share (%), By Country, 2017-2031F
• Figure 147. Saudi Arabia Urinalysis Market, By Value, in USD Billion, 2017-2031F
• Figure 148. Saudi Arabia Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
• Figure 149. Saudi Arabia Urinalysis Market Share (%), By Product, 2017-2031F
• Figure 150. Saudi Arabia Urinalysis Market Share (%), By Application, 2017-2031F
• Figure 151. Saudi Arabia Urinalysis Market Share (%), By End-user, 2017-2031F
• Figure 152. UAE Urinalysis Market, By Value, in USD Billion, 2017-2031F
• Figure 153. UAE Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
• Figure 154. UAE Urinalysis Market Share (%), By Product, 2017-2031F
• Figure 155. UAE Urinalysis Market Share (%), By Application, 2017-2031F
• Figure 156. UAE Urinalysis Market Share (%), By End-user, 2017-2031F
• Figure 157. South Africa Urinalysis Market, By Value, in USD Billion, 2017-2031F
• Figure 158. South Africa Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
• Figure 159. South Africa Urinalysis Market Share (%), By Product, 2017-2031F
• Figure 160. South Africa Urinalysis Market Share (%), By Application, 2017-2031F
• Figure 161. South Africa Urinalysis Market Share (%), By End-user, 2017-2031F
• Figure 162. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 163. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 164. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 165. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023

Global urinalysis market is projected to witness a CAGR of 5.77% during the forecast period 2024-2031, growing from USD 4.11 billion in 2023 to USD 6.44 billion in 2031.

The significant expansion of the global urinalysis market stems from various driving forces, such as growing demand for at-home testing, collaborative endeavors among major companies, favorable technological advancements, emphasis on preventive healthcare, and a rise in chronic ailments, especially among aging demographics.

There is a rising inclination toward at-home urinalysis devices, driven by the public's preference for self-care and tailored health management. These user-friendly tools enable independent health monitoring, facilitating early identification and handling of potential health issues. Partnerships between key industry players stimulate joint innovation, combining expertise, resources, and technological prowess. Such partnerships foster the advancement of sophisticated urinalysis solutions, broadening the global urinalysis market presence and enriching product offerings. Continuous advancements, notably in artificial intelligence (AI), automation, and portable devices, transform the landscape of urinalysis. These advancements notably enhance diagnostic processes' speed, precision, and convenience, thereby empowering both healthcare providers and individuals.

Healthcare trends increasingly focus on preventive measures, encouraging the adoption and development of urinalysis tools for early disease detection. Proactive health monitoring aligns with the aim of preventing illnesses before they escalate. The upsurge in chronic illnesses, combined with a globally aging population, drives the necessity for frequent urinalysis. With age-related health concerns rising, the demand intensifies for efficient and precise diagnostic instruments, propelling the expansion of the global urinalysis market. These interconnected elements collectively propel the dynamic growth of the global urinalysis market, molding it to cater to the evolving healthcare requisites of individuals and communities worldwide.

Increasing Focus on Preventive Healthcare

The growing emphasis on preventive healthcare significantly drives the expansion of the global urinalysis market. This focus stimulates the creation and application of urinalysis solutions for early disease detection. Urinalysis plays a crucial role in preventive healthcare by identifying potential health issues, enabling swift interventions, and halting disease progression. With healthcare models prioritizing prevention, there's an increased demand for precise urinalysis tools. This heightened demand solidifies their importance, establishing them as vital components in advancing worldwide healthcare strategies focused on proactive health management. Urinalysis contributes to the transition from reactive to proactive healthcare, fostering an ethos of early detection and intervention to enhance global health outcomes.

Technological Advancements

Technological advancements, particularly AI, are vital in driving the global urinalysis market. AI's incorporation brings about a revolution in urinalysis by significantly improving the accuracy, efficiency, and speed of analyzing and interpreting test results. By employing machine learning (ML) algorithms, AI rapidly recognizes patterns, irregularities, and potential health markers present in urine samples. This innovative technology streamlines diagnostic procedures, enabling faster and more precise identification of diseases or ailments. AI's capacity to learn and adapt enhances diagnostic capabilities, fostering a transition towards more tailored and efficient healthcare solutions. Its integration is pivotal in advancing urinalysis, amplifying its influence within global healthcare frameworks.

For example, in September 2022, the Israeli medical device startup Olive Diagnostics introduced a urinalysis equipment driven by artificial intelligence. The flagship product from Olive Diagnostics, Olive KG, is the first AI- and spectroscopy-based gadget in the world. It provides high-quality analysis of significant parameters in the patient's urine during each urination in a completely passive manner and doesn't require any further attachments.

Growing Popularity of Automated Urine Sediment Analyzer

The increasing adoption of automated urine sediment analyzers significantly boosts the global urinalysis market. These sophisticated systems streamline urine sample analysis by automating sediment examination, leading to heightened precision, speed, and effectiveness in identifying irregularities, thus facilitating faster and more accurate diagnoses. Furthermore, automation minimizes manual errors and labor-intensive processes, elevating reliability and throughput. This surge in usage mirrors the healthcare sector's amplified need for swift, precise, and consistent urinalysis, establishing automated urine sediment analyzers as crucial drivers behind the market's growth.

For instance, the world's first smart toilet clip-on device that would aid in the early diagnosis of health concerns was revealed by the wellness application Vivoo in January 2023. Launched at CES 2023 in Las Vegas, the smart toilet clip-on device can be added to current toilets and includes a urine strip in its seat. The risk of mess that can arise from handheld urine strips is eliminated when the strip automatically moves to align with the user's urine stream.

Growing Demand for At-home Devices

The increasing desire for at-home urinalysis devices is a significant driving force behind the global urinalysis market. These compact tools align with the growing trend of personalized healthcare, granting individuals the convenience of self-monitoring. Offering ease, precision, and instant insights, these devices empower users to oversee diverse health indicators within their home environment. Advancements in technology ensure accessible and prompt results, promoting proactive health maintenance. The rising inclination toward self-tracking and preventive healthcare further emphasizes the necessity for at-home urinalysis devices, establishing them as pivotal contributors to expanding the global urinalysis market.

For example, in January 2023, the medical device company Starling Medical announced the debut of StarStream, an at-home urine diagnostic patient monitoring platform. In contrast to traditional collection receptacles or dipsticks, StarStream examines the urine sample immediately.

Future Market Scenario (2024-2031F)

The future of the global urinalysis market looks promising, driven by several key factors. Technological advancements in AI and automation continually refine and improve urinalysis capabilities, enhancing diagnostic precision and efficiency. Growing demand for at-home testing devices and the emphasis on preventive healthcare further boost the growth of the global urinalysis market, meeting the demand for convenient proactive health monitoring solutions. Collaborations among industry leaders foster innovation, facilitating the development of sophisticated urinalysis tools. With an aging population and a rise in chronic conditions, the necessity for reliable and rapid diagnostic methods intensifies, strengthening the market's potential. These factors position the global urinalysis market for sustained expansion, addressing evolving healthcare needs and propelling advancements in diagnostic technologies worldwide for enhanced healthcare outcomes.

Key Players Landscape and Outlook

Large corporations in the global urinalysis market are progressively choosing to collaborate, merging their strengths. Through this union, these firms combine resources, research capabilities, and knowledge, nurturing innovation and broadening market reach. Such joint endeavors frequently result in the creation of state-of-the-art diagnostic technologies, innovative testing approaches, and improved product ranges. These partnerships also ease entry into new markets, stimulating growth and competitiveness. Ultimately, these collaborations cultivate a synergy that enables companies to better address evolving healthcare demands, delivering advanced urinalysis solutions on a global scale in a more comprehensive and efficient manner.

For example, in May 2023, Boehringer announced its partnership with Healthy.io to develop the first at-home, smartphone-based diagnostic tool, known as Minuteful Kidney Test, for screening individuals for chronic kidney disease (CKD). The traditional albumin-to-creatinine ratio (ACR) test, which finds protein in the urine and may indicate kidney disease at earlier stages, can be performed using the Minuteful Kidney test.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Urinalysis Market Outlook, 2017-2031F

• 4.1. Market Size & Forecast
  • 4.1.1. Value
  • 4.1.2. Volume
• 4.2. By Product
  • 4.2.1. Instruments
    • 4.2.1.1. Automated Urine Sediment Analyzer
    • 4.2.1.2. Biochemical Urine Analyzer
  • 4.2.2. Consumables
    • 4.2.2.1. Reagents
    • 4.2.2.2. Dipsticks
    • 4.2.2.3. Disposables
• 4.3. By Application
  • 4.3.1. Urinary Tract Infections (UTI)
  • 4.3.2. Diabetes
  • 4.3.3. Pregnancy
  • 4.3.4. Kidney Disease
  • 4.3.5. Others
• 4.4. By End-user
  • 4.4.1. Hospitals
  • 4.4.2. Home Healthcare
  • 4.4.3. Clinical Laboratories
  • 4.4.4. Others
• 4.5. By Region
  • 4.5.1. North America
  • 4.5.2. Europe
  • 4.5.3. South America
  • 4.5.4. Asia-Pacific
  • 4.5.5. Middle East and Africa
• 4.6. By Company Market Share (%), 2023

5. Global Urinalysis Market Outlook, By Region, 2017-2031F

• 5.1. North America*
  • 5.1.1. Market Size & Forecast
    • 5.1.1.1. Value
    • 5.1.1.2. Volume
  • 5.1.2. By Product
    • 5.1.2.1. Instruments
    • 5.1.2.1.1. Automated Urine Sediment Analyzer
    • 5.1.2.1.2. Biochemical Urine Analyzer
    • 5.1.2.2. Consumables
    • 5.1.2.2.1. Reagents
    • 5.1.2.2.2. Dipsticks
    • 5.1.2.2.3. Disposables
  • 5.1.3. By Application
    • 5.1.3.1.1. Urinary Tract Infections (UTI)
    • 5.1.3.1.2. Diabetes
    • 5.1.3.1.3. Pregnancy
    • 5.1.3.1.4. Kidney Disease
    • 5.1.3.1.5. Others
  • 5.1.4. By End-user
    • 5.1.4.1.1. Hospitals
    • 5.1.4.1.2. Home Healthcare
    • 5.1.4.1.3. Clinical Laboratories
    • 5.1.4.1.4. Others
  • 5.1.5. United States*
    • 5.1.5.1. Market Size & Forecast
    • 5.1.5.1.1. Value
    • 5.1.5.1.2. Volume
    • 5.1.5.2. By Product
    • 5.1.5.2.1. Instruments
    • 5.1.5.2.1.1. Automated Urine Sediment Analyzer
    • 5.1.5.2.1.2. Biochemical Urine Analyzer
    • 5.1.5.2.2. Consumables
    • 5.1.5.2.2.1. Reagents
    • 5.1.5.2.2.2. Dipsticks
    • 5.1.5.2.2.3. Disposables
    • 5.1.5.3. By Application
    • 5.1.5.3.1. Urinary Tract Infections (UTI)
    • 5.1.5.3.2. Diabetes
    • 5.1.5.3.3. Pregnancy
    • 5.1.5.3.4. Kidney Disease
    • 5.1.5.3.5. Others
    • 5.1.5.4. By End-user
    • 5.1.5.4.1. Hospitals
    • 5.1.5.4.2. Home Healthcare
    • 5.1.5.4.3. Clinical Laboratories
    • 5.1.5.4.4. Others
  • 5.1.6. Canada
  • 5.1.7. Mexico

All segments will be provided for all regions and countries covered

• 5.2. Europe
  • 5.2.1. Germany
  • 5.2.2. France
  • 5.2.3. Italy
  • 5.2.4. United Kingdom
  • 5.2.5. Russia
  • 5.2.6. Netherlands
  • 5.2.7. Spain
  • 5.2.8. Turkey
  • 5.2.9. Poland
• 5.3. South America
  • 5.3.1. Brazil
  • 5.3.2. Argentina
• 5.4. Asia-Pacific
  • 5.4.1. India
  • 5.4.2. China
  • 5.4.3. Japan
  • 5.4.4. Australia
  • 5.4.5. Vietnam
  • 5.4.6. South Korea
  • 5.4.7. Indonesia
  • 5.4.8. Philippines
• 5.5. Middle East & Africa
  • 5.5.1. Saudi Arabia
  • 5.5.2. UAE
  • 5.5.3. South Africa

6. Market Mapping, 2023

• 6.1. By Products
• 6.2. By Application
• 6.3. By End-user
• 6.4. By Region

7. Macro Environment and Industry Structure

• 7.1. Supply Demand Analysis
• 7.2. Import Export Analysis
• 7.3. Value Chain Analysis
• 7.4. PESTEL Analysis
  • 7.4.1. Political Factors
  • 7.4.2. Economic System
  • 7.4.3. Social Implications
  • 7.4.4. Technological Advancements
  • 7.4.5. Environmental Impacts, Legal Compliances and Regulatory Policies (Statutory Bodies Included)
• 7.5. Porter's Five Forces Analysis
  • 7.5.1. Supplier Power
  • 7.5.2. Buyer Power
  • 7.5.3. Substitution Threat
  • 7.5.4. Threat from New Entrant
  • 7.5.5. Competitive Rivalry

8. Market Dynamics

• 8.1. Growth Drivers
• 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

• 9.1. Clinical Trials
• 9.2. Patent Landscape
• 9.3. Regulatory Approvals
• 9.4. Innovations/Emerging Technologies

10. Key Players Landscape

• 10.1. Competition Matrix of Top Five Market Leaders
• 10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
• 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
• 10.4. SWOT Analysis (For Five Market Players)
• 10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

• 13.1. F. Hoffmann-La Roche Ltd.
  • 13.1.1. Company Details
  • 13.1.2. Key Management Personnel
  • 13.1.3. Products & Services
  • 13.1.4. Financials (As reported)
  • 13.1.5. Key Market Focus & Geographical Presence
  • 13.1.6. Recent Developments
• 13.2. Danaher Corporation
• 13.3. Cardinal Health, Inc.
• 13.4. Sysmex Corporation
• 13.5. Quidel Corporation
• 13.6. Siemens Healthineers AG
• 13.7. Thermo Fisher Scientific Inc.
• 13.8. Abbott Laboratories
• 13.9. Bio-Rad Laboratories, Inc.
• 13.10. EKF Diagnostics
• 13.11. Becton, Dickinson and Company

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

14. Strategic Recommendations

15. About Us & Disclaimer